GC3’s BIO-sin-thesys Network connects the premiere U.S. cluster for biotechnology development in the U.S. Mid-Atlantic with dynamic, emerging biotechnology markets of Asia:
U.S. Mid-Atlantic:
• Regional base for biotechs (E&Y Global Biotech Report 2005)
• Home to 90% of U.S. pharmaceutical market (southern NJ/southeastern PA)
• N.I.H., the world’s largest funder of biotechnology innovation (Bethesda, MD)
• Access to New York capital markets & mid-Atlantic venture funds (NYC, etc)
• Nation’s ‘foundation legacy’ for healthcare education/delivery ( Philadelphia)
• Premier educational hotbeds for innovation (Princeton, UPenn, JHU, etc)
Asia’s Emerging Biotech Markets:
• ‘The Nimble Three’: Hong Kong
Singapore
Taiwan
• ‘Tomorrow’s Giants’: China
India
The BIO-sin-thesys Global Resource Network has its own experts in place in
Philadelphia, New York and Washington DC for the U.S. Mid-Atlantic and in eleven strategic locations
in Asia (HK, Singapore, Taipei, Beijing/Tianjin, Shanghai/Nanjing,Shenzhen, Chongqing/Xian,
New Delhi, Bombay, Bangalore/Kerala and Calcutta)
GC3’s BIO-sin-thesys Network offers a bi-directional array of customized services for bridging the U.S. Mid-Atlantic and Asia.
• Custom Market Information
• Custom Market Access Facilitation
• Custom Incubation Solutions
• Custom Research Facilitation
• Bio-Park Infrastructure Advisory Services
• Bio-Based/Exchange-Traded Financial Advisory Service
GC3’s BIO-sin-thesys Network can help convert your company/organization’s investment in BIO2005 into a low-cost/high-return program of reliable execution and delivery.
BIO-sin-thesys promises to deliver as your ‘partner without peer’ based on GC3 Strategy’s unique value proposition of top-tier talent, low-cost infrastructure in key markets, and unrivalled global connectivity and insight. Please visit www.gc3s.com
Small
Companies | Medium
Companies
Large
companies | Financial
Institutions
BIO-sin-thesys
Life Science Network
|
